U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Show Filters
Hide Filters
Development Status
US Approved Rx
3
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Approval Year
2004
1
2006
1
2011
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Class
Protein
3
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Code System
ChEMBL
3
DAILYMED
3
DRUG BANK
3
DRUG CENTRAL
3
EMA ASSESSMENT REPORTS
3
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Protein Type
FAB
1
MONOCLONAL ANTIBODY
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 1
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
2
SENSORY ORGANS
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 2
ANTINEOPLASTIC AGENTS
2
OPHTHALMOLOGICALS
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 3
OCULAR VASCULAR DISORDER AGENTS
2
OTHER ANTINEOPLASTIC AGENTS
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 4
Antineovascularisation agents
2
Monoclonal antibodies
1
Other antineoplastic agents
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Form
Principal Form
3
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Search results for
"Established Pharmacologic Class [EPC]|Vascular Endothelial Growth Factor Inhibitor [EPC]"
in
comments
(approximate match)
Showing
1 - 3
of
3
results
Search within data set
First page disabled
Previous page disabled
1
Next page disabled
Next page disabled
Sort By
Approval Year, Recent
Approval Year, Oldest
Relevance
Display Name, A-Z
Display Name, Z-A
Least References
Most References
Oldest Change
Newest Change
AFLIBERCEPT
MORE DETAILS
15C2VL427D
Subunit
1
(431) Similarity Search
Subunit
2
(431) Similarity Search
Export Data
Sequence Search
Subunit
1
(431) Similarity Search
Subunit
2
(431) Similarity Search
Status:
US Approved Rx (2024)
First approved in 2011
Class:
PROTEIN
RANIBIZUMAB
MORE DETAILS
ZL1R02VT79
Subunit
1
(231) Similarity Search
Subunit
2
(214) Similarity Search
Export Data
Sequence Search
Subunit
1
(231) Similarity Search
Subunit
2
(214) Similarity Search
Status:
US Approved Rx (2021)
First approved in 2006
Class:
PROTEIN
BEVACIZUMAB
MORE DETAILS
2S9ZZM9Q9V
Subunit
1
(453) Similarity Search
Subunit
2
(453) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Export Data
Sequence Search
Subunit
1
(453) Similarity Search
Subunit
2
(453) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Status:
US Approved Rx (2022)
First approved in 2004
Class:
PROTEIN
